Methods and compositions for sequencing a nucleic acid

Abstract

The invention provides a family of tethered nucleotide analogs useful in sequencing nucleic acids containing a homopolymer region comprising, for example, two or more base repeats, and to sequencing methods using such tethered nucleotide analogs.

1 . A nucleoside triphosphate analog comprising a chemical structure within the following formula: 
     
       
         
         
             
             
         
       
     
     wherein:
 NTP is a nucleoside triphosphate or analog thereof capable of incorporating onto the 3′ end of a polynucleotide strand hybridized to a template presenting the complement of said NTP; 
 R1 is an alkyl, alkenyl, or alkyl amide;
 R2 is a cleavable bond or group; 
 
 R3 and R4 independently are an alkyl, alkenyl, alkyl amide, aryl, ether, or ester; R 4  is selected from the group consisting of: OH, phosphoryl, sulfate, NH 2 , SH, an amino acid, a peptide comprising 1 to 12 amino acids, 
 
     
       
         
         
             
             
         
       
       Y, at each occurrence, independently is O or S; 
       and Z represents H or a halogen. 
       R5 and R6 are independently 
       selected from the group consisting of: H, OH, phosphoryl, P 2 O 7   -3 , sulfate, NH 2 , SH, or a halogen 
       X is selected from the group consisting of: O, S, or CH 
     
   
   
       2 . The analog of  claim 1  wherein said cleavable bond is selected from: a disulfide bond, an ester, an azo bond, and an amido bond. 
   
   
       3 . The analog of  claim 1  wherein said Base and the nitrogenous base of said NTP are different bases. 
   
   
       4 . The analog of  claim 1  wherein said Base and the nitrogenous base of said NTP are each independently selected from the group consisting of: cytosine, uracil, thymine, adenine, guanine, and analogs thereof. 
   
   
       5 . The analog of  claim 1  wherein R6 is selected from the group consisting of PO 4   -2  and SO 4   - . 
   
   
       6 . The analog of  claim 1  wherein R4 is selected from the group consisting of PO 4   -2 , SO 4 , P 2 O 7   -3 , PO 3 S -2 , and P 2 O 6 S 2   3- . 
   
   
       7 . The analog of  claim 1  wherein Z is flourine. 
   
   
       8 . The analog of  claim 1  wherein R 5  is H or OH, and R4 and R6 are each independently PO 4   -2  or SO 4   - . 
   
   
       9 . The analog of  claim 1  wherein R3 comprises ethylene glycol or propylene glycol. 
   
   
       10 . The analog of  claim 1  wherein R3 comprises a diethylene glycol or dipropylene glycol. 
   
   
       11 . The analog of  claim 10  wherein R3 is polyethylene glycol. 
   
   
       12 . The analog of  claim 1  wherein R3 comprises at least one of: ester, amide, ether, divalent alkyl, divalent alkenyl, or divalent alkynyl. 
   
   
       13 . The analog of  claim 1  wherein said Base is deaza adenine or deaza guanine and R3 is linked to the C-7 or C-8 position of said deaza adenine or deaza guanine. 
   
   
       14 . The analog of  claim 1  wherein said base is thymine, cytosine, or uracil and R3 is linked to the N-3 or C-5 positions of said thymine, cytosine, or uracil. 
   
   
       15 . The analog of  claim 1 , wherein said Label is an optically-detectable label. 
   
   
       16 . The analog of  claim 15 , wherein said optically-detectable label is a fluorophore. 
   
   
       17 . The analog of  claim 16 , wherein said fluorophore is selected from the group consisting of: 
   
   
       18 . A molecule having a structure selected from the group consisting of: 
     
       
         
         
             
             
         
       
     
     Wherein L is a detectable label and n is from 1 to 10; 
     
       
         
         
             
             
         
       
     
     Wherein L is a detectable label, Base1 and Base2 are independently selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing, and n is from 1 to 10; 
     
       
         
         
             
             
         
       
     
     Wherein L is a detectable label, Base1 and Base2 are independently selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing, and n is from 1 to 10. 
   
   
       19 . A molecule having the following structure: 
     
       
         
         
             
             
         
       
     
     Wherein, R 1  is a dectable label, R 2  is an alkyl, alkenyl, amide, or ether, and Base1 and Base2 are independently selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing. 
   
   
       20 . A molecule having the following structure: 
     
       
         
         
             
             
         
       
     
     Wherein Base1 and Base 2 are independently is selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing; R1 is a detectable label; and R2 is an alkyl, alkenyl, amide, or ether. 
   
   
       21 . A molecule having the following structure: 
     
       
         
         
             
             
         
       
     
     Wherein Base1 and Base 2 are independently is selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing; and R1 is a detectable label. 
   
   
       22 . A molecule having the following structure: 
     
       
         
         
             
             
         
       
     
     Wherein Base is selected from adenine, thymine, guanine, cytosine, uracil and derivatives of the foregoing and R1 is a detectable label. 
   
   
       23 . A molecule having the following structure: 
     
       
         
         
             
             
         
       
     
     Wherein Base1 and Base 2 are independently is selected from adenine, thymine, guanine, cytosine, uracil and derivatives of any of the foregoing; R1 is a detectable label, R2 is selected from OH and PO 3   - , R3 is selected from a monophosphate, a diphosphate, a triphosphate, and OH, and n is from about 1 to about 10 atoms in length. 
   
   
       19 . A method of sequencing a nucleic acid , the method comprising the steps of:
 a) contacting a field of template molecules and primers annealed thereto with an analog of any of  claims 1 - 23  in the presence of a polymerase to extend said primers by covalent attachment of one analog in a template-dependent manner;   b) washing the field to remove non-covalently attached analog;   c) detecting signal from label bound to said attached analog;   d) cleaving said cleavable bond thereby separating said label from said NTP; and   e) repeating steps a) through d).